IC
Schedule 13G filing
Integrated Core Strategies (US) LLC cut its KPTI stake below 5%
Integrated Core Strategies (US) LLC reported owning 0.2% of Karyopharm Therapeutics Inc. (KPTI) (42,888 shares) in a Schedule 13G filed Oct 28, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 28, 2026
- Source
- Schedule 13G
More KPTI insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.